Maporal Virus as a Surrogate for Pathogenic New World Hantaviruses and its Inhibition by Favipiravir
Background:
Pathogenic hantaviruses geographically distributed in the Old World cause haemorrhagic fever with renal syndrome (HFRS), whereas New World hantaviruses are the aetiological agents of hantavirus cardiopulmonary syndrome (HCPS). Ribavirin, a drug associated with toxicities, is presently indicated for treatment of HFRS, whereas treatment of the more frequently lethal HCPS is limited to supportive care. Because of the need for safe and effective antivirals to treat severe hantaviral infections, we evaluated favipiravir (T-705) against Dobrava and Maporal viruses as representative Old World and New World hantaviruses, respectively. Dobrava virus causes HFRS in Europe. Maporal virus (MPRLV), recently isolated from western Venezuela, is phylogenetically similar to Andes virus, the principal cause of HCPS in Argentina.
Methods:
Hantavirus replication in the presence of various inhibitors was measured by focus-forming unit assays and quantitative reverse transcriptase PCR. Phylogenetic relationships were assessed by the neighbour-joining and bootstrap consensus methods.
Results:
Here, we show that infection of Vero E6 cells with MPRLV is dependent on β3 integrins, similar to that reported for pathogenic hantaviruses. Furthermore, by analysis of molecular determinants associated with the G1 glycoprotein cytoplasmic tail, we show the close genetic proximity of MPRLV to other HCPS-causing hantaviruses in these regions predictive of pathogenicity. We also demonstrate anti-hantavirus activity by favipiravir with inhibitory concentrations ranging from 65 to 93 μM and selectivity indices >50.
Conclusions:
Our data suggest that MPRLV may serve as a safer alternative to modelling infection caused by the highly lethal Andes virus and that hantaviruses are sensitive to the effects of favipiravir in cell culture.
Топ-30
Журналы
|
1
2
3
4
5
6
|
|
|
Antiviral Research
6 публикаций, 15.38%
|
|
|
PLoS Neglected Tropical Diseases
3 публикации, 7.69%
|
|
|
Antimicrobial Agents and Chemotherapy
3 публикации, 7.69%
|
|
|
Frontiers in Microbiology
2 публикации, 5.13%
|
|
|
Virus Research
2 публикации, 5.13%
|
|
|
Current Drug Research Reviews
1 публикация, 2.56%
|
|
|
Mini-Reviews in Medicinal Chemistry
1 публикация, 2.56%
|
|
|
Antiviral Therapy
1 публикация, 2.56%
|
|
|
Viruses
1 публикация, 2.56%
|
|
|
Microorganisms
1 публикация, 2.56%
|
|
|
Frontiers in Pharmacology
1 публикация, 2.56%
|
|
|
Scientific Reports
1 публикация, 2.56%
|
|
|
Vaccine
1 публикация, 2.56%
|
|
|
Microbes and Infection
1 публикация, 2.56%
|
|
|
Biochemical Pharmacology
1 публикация, 2.56%
|
|
|
Reviews in Medical Virology
1 публикация, 2.56%
|
|
|
Chemistry - An Asian Journal
1 публикация, 2.56%
|
|
|
Medicinal Research Reviews
1 публикация, 2.56%
|
|
|
Emerging Microbes & Infections
1 публикация, 2.56%
|
|
|
Expert Review of Anti-Infective Therapy
1 публикация, 2.56%
|
|
|
Asian Pacific Journal of Tropical Medicine
1 публикация, 2.56%
|
|
|
Journal of Virology
1 публикация, 2.56%
|
|
|
Biofabrication
1 публикация, 2.56%
|
|
|
Russian Chemical Reviews
1 публикация, 2.56%
|
|
|
Food and Chemical Toxicology
1 публикация, 2.56%
|
|
|
Energy Transition in Brazil
1 публикация, 2.56%
|
|
|
Frontiers in Immunology
1 публикация, 2.56%
|
|
|
1
2
3
4
5
6
|
Издатели
|
2
4
6
8
10
12
|
|
|
Elsevier
12 публикаций, 30.77%
|
|
|
Frontiers Media S.A.
4 публикации, 10.26%
|
|
|
American Society for Microbiology
4 публикации, 10.26%
|
|
|
Public Library of Science (PLoS)
3 публикации, 7.69%
|
|
|
Wiley
3 публикации, 7.69%
|
|
|
Bentham Science Publishers Ltd.
2 публикации, 5.13%
|
|
|
MDPI
2 публикации, 5.13%
|
|
|
Springer Nature
2 публикации, 5.13%
|
|
|
Taylor & Francis
2 публикации, 5.13%
|
|
|
SAGE
1 публикация, 2.56%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 2.56%
|
|
|
IOP Publishing
1 публикация, 2.56%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 2.56%
|
|
|
2
4
6
8
10
12
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.